Health4 years ago
NIH tests lemdecivir with Merck KGaA interferon therapy as COVID-19 treatment
National Institutes of Health is a member of Gilead Sciences Inc. GILD, + 0.48% Remdesivir with Merck KGaA MRK, -0.35% Interferon beta-1a as a treatment for...
Recent Comments